Device Center Scientists Cite Business Interests As A Factor In Decision-Making
This article was originally published in The Gray Sheet
Union of Concerned Scientists survey finds that many FDA scientists feel that business interests affect agency decisions. Nevertheless, a strong majority said that the agency is effectively protecting public health.
You may also be interested in...
Six current and former employees of FDA’s device center file suit in the U.S. District Court in Washington, D.C., arguing that email and computer surveillance violated their constitutional and legal whistleblower rights.
FDA plans to publicly issue its staff manual on scientific integrity in the near future.
FDA pre-market approval reviews tend to take longer when the medical officer leaves the review team, when clinical trial data issues arise and when companies engage in "excessive" back and forth with FDA during the review process, according to a recent FDA analysis.